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Two suitable methods for the synthesis of the heparin degradation product 2,5-anyhydro-3-O-(a-l-ido-
pyranosyluronate)-d-mannitol hexa O-sulfate are reported. The synthesis pathways start from d-glu-
cose and d-glucosamine.
1. Indroduction
The application of glycosaminoglycans (GAGs), especially
heparin and related molecules in the treatment of asthma
is well documented in the literature (Diamant and Page
2000; Jerzynska et al. 2000; Lever and Page 2001). The
mechanism involved in the control of bronchial hyperreac-
tivity by these compounds is poorly understood (Jerzynska
et al. 2000). Nevertheless it was proved, that heparin inhi-
bits allergen-induced eosinophil infiltration into guinea-pig
lung via a mechanism unrelated to its anticoagulant activ-
ity (Seeds and Page 2001). This biological activity is inde-
pendent of the anticoagulant activity of native heparin,
and is displayed by low, and even ultralow molecular
weight heparin fragments, obtained by degradation of the
original GAGs (Ahmed et al. 1997; Ahmed and Gables
1999). Recently it was claimed (Ahmed and Smith 2002)
that hypersulfated disaccharides, obtained by degradation
of heparin with HNO2 and subsequent chemical manipula-
tions (reduction with NaBH4 and sulfation) possess pro-
nounced antiasthmatic activity. It is well known (Jacobson
et al. 1979), that the primary degradation product obtained
by depolymerisation of GAGs by HNO2 corresponds to
the tetrasaccharide 1 which after further hydrolysis and
subsequent reduction with NaBH4 results in a mixture,
containing the disaccharide 2 as the major component. Ac-
cordingly the structure of the main component obtained
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after sulfation corresponds to the hepta sodium salt of 2,5-
anhydro-3-O-(a-l-idopyranosyluronate)-d-mannitol hexa-
O-sulfate (3). (Scheme 1) As the purification of the depoly-
merisation products is a very difficult process, we decided
to synthesize 3 by chemical methods, starting from D-glu-
cose (4) and D-glucosamine (5), respectively.
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2. Investigations and results
The following four transformations are necessary to con-
vert d-glucose 4 into the target compound 3 i.e. A) Oxida-
tion of the terminal hydroxymethyl group into a carboxyl
group; B) Inversion of configuration at C-5; C) Glycosida-
tion of OH-3 of the proper aglycon (6) with a-stereo-
chemistry; and D) Sulfation of all free OH groups of the
so obtained a-l-uronide 7 (Scheme 2). As far as the strat-
egy is concerned, there are two possibilities differing in
the sequence of these transformations. According to Route
a the sequence is B!A! C!D , while Route b differs
from it in the order of the oxidation and glycosidation, i.e.
the sequence is B! C! A! D.
2.1. Conversion of d-glucose into l-idose
Despite the fact, that many approaches were published in the
literature for the transformation of d-glucose into l-idose
(Reichstein 1946; Vargha 1954; Meyer; Buss et al. 1965;
Blanc-Musser; Defaye 1977; Boeckel et al.1985; Chiba;
Sinay 1986; Lee 1988; Marra et al. 1989; Hiebl; Zbiral
1990; Kovensky et al. 1996; Tabeur et al. 1996; Barroca;
Jacquinet 2000; Pellissier 2002; Barroca; Jacquinet 2002;
Orgueira et al. 2003), we used the method, developed by
Boeckel et al. 1985 for the large scale preparation of the
3-O-benzyl derivative 15 with some modifications
(Scheme 3). Accordingly d-glucose was converted into its
1,2 : 5,6-di-O-isopropylidene derivative 8 the free 3-OH
group of which was protected by benzylation. The so ob-
tained crude syrupy product 9 was partially hydrolyzed
and the obtained 5,6-dihydroxy compound 10 was purified
by converting it into it crystalline di-O-acetate 11. Deace-
tylation of the latter with sodium methoxide in methanol,
followed by mesylation led to the crystalline 5,6-di-O-me-
sylate 12 the terminal mesyloxy group of which was ex-
changed with an acetoxy goup by heating it in DMSO
solution with sodium acetate. The formed crystalline
mixed ester 13 gave on treatment with sodium-isopropox-
ide in isopropanol the desired l-ido-epoxide 14 in excel-
lent yield. Acidic hydrolysis of the latter gave a mixture,
containing besides 3-O-benzyl-l-idopyranose 15 several
by-products, therefore it had to be converted into the
anomeric mixture of its peracetate 16 which could be pur-
ified by column chromatography. This compound was the
key intermediate used as starting material in both, Route a
and Route b.
2.2. Attempted synthesis of 3 according to Route a
Deacetylation of 16 was carried out with sodium methox-
ide in methanol and the obtained pyranose 15 was treated
with benzaldehyde dimethylacetal for converting it into the
4,6-O-benzylidene derivative 17 described first by Tabeur
et al. 1996. The benzylidene group was removed after acet-
ylation from the anomeric mixture of the di-O-acetates 18
and the terminal OH group of the 4,6-dihydroxy derivative
19 was temporarily protected by silylation with
TBDMSiCl. The remaining free 4-OH group of the ob-
tained diacetate 20 was acetylated and the silyl group was
removed from the obtained triacetate 21 by treatment with
sulfuric acid in methanol. However, under these conditions
a partial 4-OAc! 6-OAc acetyl migration took place and
the corresponding triacetate isomers 22 and 23 were
formed in a ratio of 1 : 2 and had to be separated by col-
umn chromatography. The 1,2,4-tri-O-acetate 23, contain-
ing a free 6-OH group was submitted to oxidation using
NaOCl in the presence of TEMPO as reagent (Davis and
Flitsch 1993) (Scheme 4). The obtained carboxylic acid 25
was converted into its methyl ester 26 which on treatment
with thiophenol in the presence of boron trifluoride af-
forded the a-anomer of thioglycoside 27 which was used
as donor in the glycosylation reaction of 1,6-di-O-benzoyl-
2,5-anhydro-d-mannitol 28 (Otero and Simpson 1984).
The latter contains two adjacent secondary free OH
groups, but because of the C2 symmetry of the molecule,
glycosidation of either of them will lead to the same mono-
glycoside 29. For the glycosidation reaction NIS was used
as activator in the presence of a catalytic amount of TfOH,
but the yield was very low (21%) and could not be in-
creased by changing the conditions. This was not com-
pletely unexpected, as Tabeur at al.1996 failed too in
glycosylating a secondary OH group using a similar thio-
glycoside. The overall yield of this approach could be
somewhat increased by shortening the synthesis, as the
dihydroxy derivative 19 could also be selectively oxidized
to the corresponding carboxylic acid 24, which could be
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i) NaOCl/TEMPO; KHCO3/DMF, 61%; ii) PhSH/BF3, 52%; iii) NIS/TfOH, 21%
converted into 26 by acetylation of the free 4-OH group.
Nevertheless the difficulties, which arouse during the
desilylation procedure as well as the low yield of the gly-
cosidation reaction made this approach disadvantageous,
therefore no further attempts were made to convert 29 into
the target compound 3.
2.3. Synthesis of 3 according to Route b
The synthesis of the 1,2,4,6-tetra-O-acetyl-3-O-benzyl-l-
idopyranose intermediate 15 was carried out as described
for Route a. This was converted into the corresponding
phenyl thioglycoside 30 using boron trifluoride as promo-
ter (Scheme 5). The trihydroxy derivative 31 obtained
after deacetylation was converted into its 4,6-O-benzyl-
idene derivative 32 which after acetylation (33) was used
as donor in the condensation with 28 applying the NIS/
TfOH system for activation. In this case the reaction pro-
ceeded extremely well and the glycoside 34 was obtained
in a yield of 84%. The O-benzyl and O-benzylidene
groups of 34 were split off simultaneously by reduction
with hydrogen over Pd/C and the trihydroxy derivative 35
was isolated as a crystalline compound. In this case the
direct oxidation of the primary OH group by NaOCl/
TEMPO failed probably because of the presence of four
free OH groups. For this reason the primary OH group
was temporarily protected by silylation and the remaining
free OH groups of the obtained silyl derivative 36 were
benzoylated. The silyl group of the obtained penta-O-
benzoate 37 could be selectively hydrolysed without any
benzoyl migration and the formed 6-OH derivative 38 af-
forded on oxidation with NaOCl/TEMPO the correspond-
ing 6-carboxylate 39 in satisfactory yield (74%). It was
not necessary to convert this acid into its ester, as on treat-
ment with sodium methoxide in methanol it gave the so-
dium salt of the deacylated disaccharide 40 which was
directly converted into its polysulfate with SO3 in DMF.
The excess of the reagent was decomposed with aqueous
NaHCO3 and the formed sulfate ions were removed with
Sr-acetate. Finally Sr ions were removed with a CHELEX
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i) PhSH/BF3, 64%; ii) NaOMe/MeOH, 97%; iii) Ph(CHOMe)2/pTsOH; Ac2O/Py, 35%; iv) NIS/TfOH, 84%; v) H2/Pd-C, 70%;
vi) TBDMSiCl/Py; BzCl/Py, 95%; vii) H2SO4/MeOH, 95%; viii) NaOCl/TEMPO, 74%; ix) NaOMe/MeOH, 82%, x) SO3/DMF; H2O/NaOAc/MeOH, 70%
100 (Na form) resin and 3 was precipitated from the concen-
trated solution with methanol. The so obtained salt contained
according to NMR (Fig.) 0.43 eq of MeOH and 0.76 eq of
NaOAc but was free from any other contaminants.
This research paper was presented during the 4th Conference on Retrometa-
bolism Based Drug Design and Targeting, May 11–14, 2003, Palm Coast,
Florida, USA.
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Fig.:
1H NMR (250 MHz) spectrum of 3 in D2O recorded
with a Bruker AC 250 spectrometer
